我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

硫酸镁协同胺碘酮转复室性心动过速的疗效分析

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第1期
页码:
62-063,067
栏目:
临床研究
出版日期:
2014-09-25

文章信息/Info

Title:
Efficacy of magnesium sulfate combined with amiodarone in treatment of refractory ventricular tachycardia
作者:
王学莉1伏 添1王成立1张西京2
(1.汉中3201医院ICU,陕西 汉中 723000;
2.第四军医大学西京医院SICU,陕西 西安 710032)
Author(s):
WANG Xue-li1 FU Tian1 WANG Cheng-li1 ZHANG Xi-jing2
(1.Intensive Care Unit, 3201 Hospital, Hanzhong 723000, Shaanxi, China;
2.Surgical Intensive Care Unit, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
心动过速室性心律转复硫酸镁胺碘酮
Keywords:
magnesium sulfate amiodarone ventricular tachycardia cardioversion
分类号:
R541.7
DOI:
-
文献标识码:
A
摘要:
目的:分析硫酸镁协同胺碘酮转复室性心动过速的疗效。方法: 回顾性分析ICU中136例室性心动过速患者,按是否联用硫酸镁将患者分成联合用药组(n=72)和对照组(n=64),分析硫酸镁协同胺碘酮的复律效果。结果: 两组患者基本情况、电转复能量、胺碘酮的负荷量及28 d病死率等比较均无统计学差别;联合用药组电转复次数[(1.4±0.9)次 vs.(3.0±2.2)次,P<0.01]和胺碘酮维持总剂量[(0.9±0.6) g vs.(2.3±1.2) g,P<0.01]显著低于对照组, 30 min转复率(33% vs. 9%,P<0.01)、24 h转复率(97% vs. 78%,P<0.01)及72 h维持成功率(97% vs. 84%,P<0.01)均显著高于对照组;联合用药组2h转复率高于对照组(81% vs. 62%,P<0.05),住ICU时间短于对照组[(7.4±3.9) d vs.(9.1±5.2) d,P<0.05)。结论: 硫酸镁联合胺碘酮转复室性心动过速的疗效优于单用胺碘酮。
Abstract:
AIM:To evaluate the efficacy of magnesium sulfate combined with amiodarone in the treatment of refractory ventricular tachycardia. METHODS: One hundred and thirty-six ICU patients with ventricular tachycardia were retrospectively analyzed. Patients were divided into two groups: magnesium sulfate group with treatment of magnesium sulfate combined with amiodarone (n=72) and amiodarone group (n=64) with treatment of amiodarone only. The cardioversion efficacy of magnesium sulfate was evaluated. RESULTS: There was no difference in aspects such as electric power, load dose of amiodarone and 28-day mortality rate between groups. The times of electric cardioversion [(1.4±0.9) times vs.(3.0±2.2) times, P<0.01] and the maintenance dose of amiodarone [(0.9±0.6) g vs.(2.3±1.2) g, P<0.01] in the magnesium sulfate group were significantly lower than those in the amiodarone group. The success rate of cardioversion in 30 min (33% vs. 9%, P<0.01) and 24 h (97% vs. 78%, P<0.01) and the rate of maintaining success for 72 h (97% vs. 84%, P<0.01) in the magnesium sulfate group were significantly higher than those in the amiodarone group. The success rate of cardioversion in 2 h in the magnesium sulfate group was higher than in the amiodarone group (81% vs. 62%, P<0.01). The period of ICU stay in the magnesium sulfate group was shorter than in the amiodarone group [(7.4±3.9) days vs.(9.1±5.2) days, P<0.05]. CONCLUSION: Magnesium sulfate combined with amiodarone has good efficacy for cardioversion and a high rate of maintaining success in patients with refractory ventricular tachycardia.

参考文献/References

[1]Zipes DP,Camm AJ,Borggrefe M,et al.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death[J].J Am Coll Cardiol,2006,48(5):e247.
[2]Dorman BH,Sade RM,Burnette JS,et al.Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects[J].Am Heart J,2000,139(3):522-528.
[3]Hoshino K,Ogawa K,Hishitani T,et al.Influence of heart surgery on Magnesium concentrations in pediatric patients[J].Pediatr Int,2003, 45(1):39-44.
[4]顾 松,苏丕雄,刘 岩,等.冠状动脉旁路移植术后心房颤动的高危因素分析[J].中华心律失常学杂志,2002,6(4):207-210.
[5]曹克将.室性心律失常的治疗进展[J].中华心律失常学杂志,2011,15(3):165-166.
[6]曾佑平,张利华.卡维地洛治疗扩张型心肌病复杂型室性心律失常的疗效评价[J].心脏杂志,2003,15(2):121-123.
[7]Shiga T,Wajima Z,Inoue T,et al.Magnesium prophylaxis for arrhythmias after cardiac surgery:a meta-analysis of randomized controlled trials[J].Am J Med,2004,117(5):325-333.
[8]Mubagwa K,Gwanyanya A,Zakharov S,et al.Regulation of cation channels in cardiac and smooth muscle cells by intracellular Magnesium[J].Arch Biochem Biophys,2007,458(1):73-89.
[9]曹艳杰,王海昌,张荣庆,等.硫酸镁抗实验性心律失常及其对钠电流的影响[J].中国心脏起搏与心电生理杂志,2005,19(6):490-492.
[10]史俊忠,杜日映,杨欣国,等.尖端扭转型室性心动过速的快速识别和治疗[J].心脏杂志,2005,17(1):55-57.

备注/Memo

备注/Memo:
收稿日期:2014-01-20.
通讯作者:张西京,副教授,主要从事心脑血管保护研究Email:zhangxj918@163.com
作者简介:王学莉,硕士生Email:xlwang3201@sina.cn
更新日期/Last Update: 2015-01-20